Cefazolin sodium - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for cefazolin sodium and what is the scope of freedom to operate?

Cefazolin sodium is the generic ingredient in eight branded drugs marketed by Glaxosmithkline, Baxter Hlthcare, B Braun, Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Dr Reddys, Facta Farma, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Hospira, Hospira Inc, Qilu, Samson Medcl, Sandoz, Steri Pharma, Teva Pharms, Lilly, Hq Spclt Pharma, and Baxter Hlthcare Corp, and is included in forty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for cefazolin sodium. Twenty-one suppliers are listed for this compound.

Summary for cefazolin sodium

US Patents:	0
Tradenames:	8
Applicants:	23
NDAs:	41
Drug Master File Entries:	18
Finished Product Suppliers / Packagers:	21
Raw Ingredient (Bulk) Api Vendors:	64
Clinical Trials:	8
Patent Applications:	4,596
What excipients (inactive ingredients) are in cefazolin sodium?	cefazolin sodium excipients list
DailyMed Link:	cefazolin sodium at DailyMed

Recent Clinical Trials for cefazolin sodium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
HK Surgical, Inc.	Phase 2/Phase 3
University of California, Riverside	Phase 2/Phase 3
University of British Columbia	Early Phase 1

See all cefazolin sodium clinical trials

Pharmacology for cefazolin sodium

Drug Class	Cephalosporin Antibacterial

Medical Subject Heading (MeSH) Categories for cefazolin sodium

Anti-Bacterial Agents

Anatomical Therapeutic Chemical (ATC) Classes for cefazolin sodium

J01DB	First-generation cephalosporins
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for cefazolin sodium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	cefazolin sodium	INJECTABLE;INJECTION	050566-001	Jun 8, 1983		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	CEFAZOLIN SODIUM	cefazolin sodium	INJECTABLE;INJECTION	063018-001	Mar 5, 1990		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Facta Farma	CEFAZOLIN SODIUM	cefazolin sodium	INJECTABLE;INJECTION	063214-001	Dec 27, 1991		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.